Cefminox Sodium Hydrate

头孢米诺钠

Report date: 2022/05/17 17:46:24
NME

Base Information

Drug NameCefminox Sodium Hydrate
Drug Alias Name头孢米诺钠水合物头孢米诺MelnoxMeicelin
ClassificationSmall molecules > Heterocyclic drugs > AntibioticsSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryJapan
Original Approved Date1987/06/30
Country/TerritoryThailandSpainSouth Korea +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesMeiji Co LtdTedec Meiji Farma SaYungjin Pharm Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ01DC12
Related LinksWikipediaKEGG